Recursion Pharmaceuticals Inc
RXRX
$5.03-0.08 (-1.57%)
Jun 22, 2025, 4:00 PM
Financials
| 52Week High | 12.36 | 52Week Low | 3.79 |
| Beta | 0.86 | Current Ratio Annual | 3.81 |
| Current Ratio Quarterly | 4.11 | Gross Margin TTM | 6.50 |
| Market Cap | 2.04B | Net Profit Margin TTM | -961.32 |
| Operating Margin TTM | -976.31 | Price To Book | 2.19 |
| Price To Sales TTM | 34.20 | Quick Ratio Annual | 3.81 |
| Quick Ratio Quarterly | 4.10 | Return On Assets TTM | -54.02 |
| Return On Equity TTM | -74.70 | Return On Investment TTM | -72.07 |
| Revenue Growth3Y | 79.46 | Revenue Growth5Y | 90.91 |
| Revenue Growth Quarterly Yoy | 6.89 | Revenue Growth TTMYoy | 29.32 |
| Revenue Per Share TTM | 0.15 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 318 | 2 | 0 | 5 | 4 | 0 | 311.20M | $2.09B |
| Mar 31, 2025 | 334 | 66 | 46 | 135 | 70 | 59 | 310.61M | $1.63B |
| Change | 16(5%) | 64(3200%) | 46 | 130(2600%) | 66(1650%) | 59 | 581.93K(0%) | $460.11M(22%) |